 | Vol. 6.21 – 15 June, 2020 |
| |
|
|
| Investigators showed that caveolae were asymmetrically distributed in melanocytes and particularly abundant at the melanocyte-keratinocyte interface in epidermis. [Nature Communications] |
|
|
|
 | PUBLICATIONSRanked by the impact factor of the journal |
| DERMAL STEM CELLS & TISSUE REGENERATION |
| | Using a Gfra1 (glial-cell-derived neurotrophic factor (GDNF) family receptor alpha 1) knock-in reporter mouse line, GDNF signaling was found to occur within hair bulge stem cells during the initiation of the hair cycle and early stages of hair formation after depilation. [NPJ Regenerative Medicine] |
| | Scientists found that prolonged expression of transgenic p16INK4a in the mouse epidermis induced hyperplasia and dysplasia, involving high proliferation rates of keratinocytes not expressing the transgene. [Nature Communications] |
| |
|
|
| Researchers showed that melanocyte-specific expression of human MX2 in a zebrafish model demonstrated accelerated melanoma formation in a BRAFV600E background. [Nature Communications] |
|
|
|
| Using a cancer cell model to trigger non-lethal caspase activation, the authors found that melanoma cancer cells undergoing failed apoptosis had a particular transcriptomic signature associated with focal adhesions, transendothelial migration, and modifications of the actin cytoskeleton. [Cell Reports] |
|
|
|
| Researchers clarified that virus invasion significantly activated MDA5 and further potentiated the keratinocyte-derived CXCL10 and CXCL16 which are the two vital chemokines for the cutaneous infiltration of CD8+ T cells in vitiligo. [Cell Death & Disease] |
|
|
|
| The authors report that over-expressed POU4F1 contributed to the acquired resistance of melanoma cells to Vemurafenib. POU4F1 also promoted the activation of ERK signaling pathway via transcriptional regulation on MEK expression. [Cell Death & Disease] |
|
|
|
| Researchers investigated the effects of endothelin-1 (ET-1) receptor antagonist on imiquimod-induced psoriasiform dermatitis in a mouse model and found that ET-1 and endothelin A receptor axis played an important role in the pathogenesis of psoriasis. [Scientific Reports] |
|
|
|
| Scientists investigated the antipsoriatic activity of topical administration of resveratrol oligomers and explored the effect of the number of resveratrol subunits on skin absorption to establish the structure-permeation relationship. [International Journal of Pharmaceutics] |
|
|
|
| Researchers have established a highly efficient method for precise deletion of critical gene sequences in primary human keratinocytes, based on CRISPR/Cas9-mediated gene editing. [Molecular Therapy-Methods & Clinical Development] |
|
|
|
| Scientists showed that IRAK-M, a negative regulator of MyD88 signaling, was deficient or low in melanoma and expression levels correlated with patient survival. Inducing IRAK-M expression using genetic approaches or epigenetic modifiers initiated apoptosis by prompting its interaction with TRAF6. [Communications Biology] |
|
|
|
|
| The authors discuss the current available repertoire of melanoma models, including two- and three-dimensional tissue cultures, organoids, genetically engineered mice and patient-derived xenograft. [Nature Communications] |
|
|
|
| Scientists discuss the essential role of mitochondria in regulating normal and abnormal skin physiology and the possibility of targeting this organelle in various skin disorders. [Cell Death & Disease] |
|
|
|
|
| A group of Australian scientists have caught the attention of NASA with a novel technology development that could potentially heal wounds in days rather than weeks without using stitches. |
|
|
|
| China’s plan to introduce a new security law in Hong Kong has prompted mixed reactions from scientists there. Some fear that such a law could lead to government interference in research, restrict participation in international collaborations and increase self-censorship, whereas others are confident that research will be unaffected. [Nature News] |
|
|
|
|
| 2020-10-12 – 2020-10-14 Paris, France |
|
|
|
|
|
| Bristol Myers Squibb – Montréal, Quebec, Canada |
|
|
|
| The Hormel Institute – Austin, Minnesota, United States |
|
|
|
| The Wistar Institute – Philadelphia, Pennsylvania, United States |
|
|
|
| Brigham and Women’s Hospital – Boston, Massachusetts, United States |
|
|
|
| The Wistar Institute – Philadelphia, Pennsylvania, United States |
|
|
|
| University of California, Davis – Sacramento, California, United States |
|
|
|
| Taro Pharmaceuticals Inc. – Brampton, Ontario, Canada |
|
|
|
| Research Institute of the McGill University Health Centre – Montreal, Quebec, Canada |
|
|
|
| Amgen Inc. – South San Francisco, California, United States |
|
|
|
| Benaroya Research Institute – Seattle, Washington, United States |
|
|
|
|